J. C. Levron

1.0k total citations
36 papers, 702 citations indexed

About

J. C. Levron is a scholar working on Anesthesiology and Pain Medicine, Surgery and Pharmacology. According to data from OpenAlex, J. C. Levron has authored 36 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Anesthesiology and Pain Medicine, 7 papers in Surgery and 7 papers in Pharmacology. Recurrent topics in J. C. Levron's work include Anesthesia and Sedative Agents (13 papers), Anesthesia and Pain Management (6 papers) and Antifungal resistance and susceptibility (5 papers). J. C. Levron is often cited by papers focused on Anesthesia and Sedative Agents (13 papers), Anesthesia and Pain Management (6 papers) and Antifungal resistance and susceptibility (5 papers). J. C. Levron collaborates with scholars based in France, Belgium and United States. J. C. Levron's co-authors include P. Duvaldestin, M. Chauvin, A Puech, D. Warot, Claudia Ferrier, Y. Bouffard, Bénédicte Lebrun‐Vignes, J Marty, B. Diquet and O. Chosidow and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Anesthesiology and British Journal of Anaesthesia.

In The Last Decade

J. C. Levron

35 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. C. Levron France 14 182 157 142 126 110 36 702
C. Andrew Robinson United States 17 129 0.7× 76 0.5× 155 1.1× 123 1.0× 48 0.4× 43 840
Prem K. Narang United States 14 146 0.8× 96 0.6× 96 0.7× 74 0.6× 85 0.8× 37 856
Elena Suárez Spain 14 61 0.3× 161 1.0× 55 0.4× 90 0.7× 98 0.9× 59 659
Jane Blood United States 14 78 0.4× 185 1.2× 215 1.5× 164 1.3× 109 1.0× 24 806
Dyal C. Garg United States 17 96 0.5× 46 0.3× 116 0.8× 100 0.8× 101 0.9× 35 808
Jean‐Claude Levron France 13 110 0.6× 234 1.5× 89 0.6× 227 1.8× 52 0.5× 19 613
Thomas R. MacGregor United States 19 695 3.8× 71 0.5× 158 1.1× 93 0.7× 171 1.6× 46 1.3k
A. Van Hecken Belgium 11 92 0.5× 57 0.4× 60 0.4× 66 0.5× 42 0.4× 14 487
Edward J. Mroszczak United States 13 132 0.7× 57 0.4× 54 0.4× 138 1.1× 136 1.2× 26 794
Peter E. Coates United Kingdom 16 93 0.5× 43 0.3× 99 0.7× 40 0.3× 83 0.8× 25 698

Countries citing papers authored by J. C. Levron

Since Specialization
Citations

This map shows the geographic impact of J. C. Levron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. C. Levron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. C. Levron more than expected).

Fields of papers citing papers by J. C. Levron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. C. Levron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. C. Levron. The network helps show where J. C. Levron may publish in the future.

Co-authorship network of co-authors of J. C. Levron

This figure shows the co-authorship network connecting the top 25 collaborators of J. C. Levron. A scholar is included among the top collaborators of J. C. Levron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. C. Levron. J. C. Levron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleyfel, M., B. Vallet, Pierre Desreumaux, et al.. (2005). Inflammation increases sufentanil requirements during surgery for inflammatory bowel diseases. European Journal of Anaesthesiology. 20(12). 957–962. 5 indexed citations
2.
Fleyfel, M., B. Vallet, Pierre Desreumaux, et al.. (2003). Inflammation increases sufentanil requirements during surgery for inflammatory bowel diseases. European Journal of Anaesthesiology. 20(12). 957–962. 3 indexed citations
3.
Lebrun‐Vignes, Bénédicte, B. Diquet, J. C. Levron, et al.. (2001). Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects. British Journal of Clinical Pharmacology. 51(5). 443–450. 98 indexed citations
4.
Pageaux, Georges‐Philippe, et al.. (2001). Pharmacokinetics of sabeluzole and dextromethorphan oxidation capacity in patients with severe hepatic dysfunction and healthy volunteers. British Journal of Clinical Pharmacology. 51(2). 164–168. 2 indexed citations
5.
Levron, J. C., et al.. (2000). Itraconazole lung concentrations in haematological patients. Mycoses. 43(3-4). 125–127. 8 indexed citations
6.
Michallet, M., Florence Persat, N Kranzhöfer, et al.. (1998). Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation. Bone Marrow Transplantation. 21(12). 1239–1243. 27 indexed citations
7.
Cheymol, G, et al.. (1997). Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects. European Journal of Clinical Pharmacology. 51(6). 493–498. 45 indexed citations
8.
Sommers, De K., et al.. (1997). Lack of effect of amitriptyline on risperidone pharmacokinetics in schizophrenic patients. International Clinical Psychopharmacology. 12(3). 141–146. 6 indexed citations
9.
Levron, J. C., et al.. (1993). Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 614(2). 333–339. 51 indexed citations
10.
Blanlœil, Y., P. Germaud, Philippe Le Conte, et al.. (1993). Aspergillose invasive en réanimation chirurgicale. Annales Françaises d Anesthésie et de Réanimation. 12(4). 379–384. 1 indexed citations
11.
Marchetti, Federico, et al.. (1993). Perfusion peropératoire de fentanyl ou de sufentanil : concentrations plasmatiques et modifications respiratoires postopératoires. Annales Françaises d Anesthésie et de Réanimation. 12(4). 357–364. 5 indexed citations
12.
Alazia, M., et al.. (1992). PHARMACOKINETICS OF LONG-TERM SUFENTANIL INFUSION (72 HOURS) USED FOR SEDATION IN I.C.U. PATIENTS. Anesthesiology. 77(Supplement). A364–A364. 3 indexed citations
13.
Levron, J. C., et al.. (1992). DO ENZYME INDUCERS MODIFY HALOPERIDOL DECANOATE RATE OF RELEASE?. Clinical Neuropharmacology. 15. 503B–503B. 1 indexed citations
14.
Levron, J. C., et al.. (1991). Pharmacocinétique de l'étomidate en perfusion continue chez le patient cirrhotique. Annales Françaises d Anesthésie et de Réanimation. 10(5). 443–449. 5 indexed citations
15.
Levron, J. C., et al.. (1990). High-performance liquid chromatographic determination of etomidate in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 529(1). 217–222. 12 indexed citations
16.
Labaille, T., D. Benhamou, J. C. Levron, & Sheila E. Cohen. (1988). C02 SENSITIVITY FOLLOWING EPIDURAL SUFENTANIL IN CESAREAN SECTION PATIENTS. Anesthesiology. 69(3A). A702–A702. 5 indexed citations
17.
18.
Alazia, M. & J. C. Levron. (1987). Etude pharmacocinétique d'une perfusion intraveineuse prolongée de fentanyl en réanimation. Annales Françaises d Anesthésie et de Réanimation. 6(5). 465–466. 3 indexed citations
19.
Levron, J. C., et al.. (1987). [Clinical pharmacokinetics of haloperidol decanoate. Comparison with other prolonged-action neuroleptics].. PubMed. 13(2). 83–7. 3 indexed citations
20.
Chauvin, M., et al.. (1985). CLINICAL ASSESSMENT AND PLASMA PHARMACOKINETICS ASSOCIATED WITH INTRAMUSCULAR OR EXTRADURAL ALFENTANIL. British Journal of Anaesthesia. 57(9). 886–891. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Andrew Robinson Breakdown of academic impact, for papers by Prem K. Narang Breakdown of academic impact, for papers by Elena Suárez Breakdown of academic impact, for papers by Jane Blood Breakdown of academic impact, for papers by Dyal C. Garg Breakdown of academic impact, for papers by Jean‐Claude Levron Breakdown of academic impact, for papers by Thomas R. MacGregor Breakdown of academic impact, for papers by A. Van Hecken Breakdown of academic impact, for papers by Edward J. Mroszczak Breakdown of academic impact, for papers by Peter E. Coates
Rankless by CCL
2026